Management Change13 Oct 2026, 12:23 pm
Senores Pharma Re-appoints MD & Whole-time Director
AI Summary
Senores Pharmaceuticals Ltd announced that its Board of Directors has re-appointed Mr. Swapnil Jatinbhai Shah as the Managing Director and Mr. Chetan Bipinchandra Shah as the Whole-time Director. Both appointments are for a period of three consecutive years, effective from October 15, 2026, and November 10, 2026, respectively. These re-appointments are subject to shareholder approval via a postal ballot process. Mr. Shah brings over 15 years of experience in the pharmaceutical sector and holds an MBA from Hofstra University. The board meeting took place on October 13, 2026.
Key Highlights
- Mr. Swapnil Jatinbhai Shah re-appointed as Managing Director.
- Mr. Chetan Bipinchandra Shah re-appointed as Whole-time Director.
- Both appointments are for a three-year term.
- Shareholder approval required via postal ballot.
- Appointments effective from mid-October and early November 2026.
Price Impact
More from SENORES